Trial intelligence / Profile preview

Butoconazole nitrate suppository for vulvovaginal candidiasis

CTR20131065Phase 2Completed

Sponsor
Nanjing Huawei Pharmaceutical Technology Development
Start
Jan 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of butoconazole in vulvovaginal candidiasis (VVC), sponsored by Nanjing Huawei Pharmaceutical Technology Development. Started Jan 2014; status: completed.

02

Drugs

butoconazole
03

Conditions

vulvovaginal candidiasis (VVC)

Beyond the preview

Go deeper on CTR20131065.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20131065.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call